Organization Overview
Historical Acquisition Tree
Alternative names
Fosdenopterin (Nulibry) (2021)
Key: Bridge Biotherapeutics, Inc. (5) Acquired (1)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1)
Pulmonary Fibrosis (Phase 1)
Ulcer (Phase 2)